These included two protein–protein interactions with: (1) the deubiquitinase USP9x, and (2) the ubiquitin ligase TRIM25, which have both been reported to promote ERG stabilisation and ERG degradation, respectively, in cancer cells (Wang et al., 2014; Wang et al., 2016). This evidence concerns the gene TRIM25 and cancer.